Inovio Pharma (INO) Tops Q1 EPS by 31c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.21 +5.22%
EPS Growth %: +75.9%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +75.9%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q1 EPS of $0.16, $0.31 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $110 thousand versus the consensus estimate of $300 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
- Investec Double Upgrades Supreme Industries (SI:IN) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
